{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:53:22Z","timestamp":1785578002208,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["23853"],"award-info":[{"award-number":["23853"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70075-5","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T14:03:23Z","timestamp":1726063403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correction of exon 2, exon 2\u20139 and exons 8\u20139 duplications in DMD patient myogenic cells by a single CRISPR\/Cas9 system"],"prefix":"10.1038","volume":"14","author":[{"given":"Juliette","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auriane","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbass","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Warthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mamchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-8336","authenticated-orcid":false,"given":"Guillaume","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-009X","authenticated-orcid":false,"given":"Matteo","family":"Bovolenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-446X","authenticated-orcid":false,"given":"Isabelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"70075_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. Jr. & Kunkel, L. M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919\u2013928. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4 (1987).","journal-title":"Cell"},{"key":"70075_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri, E., Bonnemann, C. G. & Muntoni, F. Muscular dystrophies. Lancet 394, 2025\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(19)32910-1 (2019).","journal-title":"Lancet"},{"key":"70075_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/323646a0","volume":"323","author":"AP Monaco","year":"1986","unstructured":"Monaco, A. P. et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646\u2013650. https:\/\/doi.org\/10.1038\/323646a0 (1986).","journal-title":"Nature"},{"key":"70075_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00205170","volume":"86","author":"AH Beggs","year":"1990","unstructured":"Beggs, A. H., Koenig, M., Boyce, F. M. & Kunkel, L. M. Detection of 98% of DMD\/BMD gene deletions by polymerase chain reaction. Hum. Genet. 86, 45\u201348. https:\/\/doi.org\/10.1007\/BF00205170 (1990).","journal-title":"Hum. Genet."},{"key":"70075_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1042\/BST20190282","volume":"48","author":"A Babbs","year":"2020","unstructured":"Babbs, A. et al. From diagnosis to therapy in Duchenne muscular dystrophy. Biochem. Soc. Trans. 48, 813\u2013821. https:\/\/doi.org\/10.1042\/BST20190282 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"70075_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020257","author":"H Wilton-Clark","year":"2022","unstructured":"Wilton-Clark, H. & Yokota, T. Antisense and gene therapy options for duchenne muscular dystrophy arising from mutations in the N-terminal hotspot. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13020257 (2022).","journal-title":"Genes (Basel)."},{"key":"70075_CR7","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.181","author":"N Wasala","year":"2022","unstructured":"Wasala, N. et al. Life-long outcomes of systemic AAV micro-dystrophin gene therapy in a murine Duchenne muscular dystrophy model. Hum. Gene Ther. https:\/\/doi.org\/10.1089\/hum.2022.181 (2022).","journal-title":"Hum. Gene Ther."},{"key":"70075_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.12.007","author":"JF Boehler","year":"2022","unstructured":"Boehler, J. F. et al. Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscul. Disord. https:\/\/doi.org\/10.1016\/j.nmd.2022.12.007 (2022).","journal-title":"Neuromuscul. Disord."},{"key":"70075_CR9","doi-asserted-by":"publisher","first-page":"eabo1815","DOI":"10.1126\/scitranslmed.abo1815","volume":"15","author":"SM Birch","year":"2023","unstructured":"Birch, S. M. et al. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci. Transl. Med. 15, eabo1815. https:\/\/doi.org\/10.1126\/scitranslmed.abo1815 (2023).","journal-title":"Sci. Transl. Med."},{"key":"70075_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107967","volume":"230","author":"AM Yu","year":"2022","unstructured":"Yu, A. M. & Tu, M. J. Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination. Pharmacol. Ther. 230, 107967. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107967 (2022).","journal-title":"Pharmacol. Ther."},{"key":"70075_CR11","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s40265-023-01929-x","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy, S. M. Delandistrogene moxeparvovec: First approval. Drugs 83, 1323\u20131329. https:\/\/doi.org\/10.1007\/s40265-023-01929-x (2023).","journal-title":"Drugs"},{"key":"70075_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","volume":"80","author":"YA Heo","year":"2020","unstructured":"Heo, Y. A. Golodirsen: First approval. Drugs 80, 329\u2013333. https:\/\/doi.org\/10.1007\/s40265-020-01267-2 (2020).","journal-title":"Drugs"},{"key":"70075_CR13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/acn3.51235","volume":"7","author":"H Komaki","year":"2020","unstructured":"Komaki, H. et al. Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1\/2 study. Ann. Clin. Transl. Neurol. 7, 2393\u20132408. https:\/\/doi.org\/10.1002\/acn3.51235 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"70075_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.tips.2022.04.009","volume":"43","author":"SE Zakeri","year":"2022","unstructured":"Zakeri, S. E. et al. Casimersen for the treatment of Duchenne muscular dystrophy. Trends Pharmacol. Sci. 43, 607\u2013608. https:\/\/doi.org\/10.1016\/j.tips.2022.04.009 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"70075_CR15","doi-asserted-by":"publisher","first-page":"1001263","DOI":"10.3389\/fimmu.2022.1001263","volume":"13","author":"W Shen","year":"2022","unstructured":"Shen, W., Liu, S. & Ou, L. rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis. Front. Immunol. 13, 1001263. https:\/\/doi.org\/10.3389\/fimmu.2022.1001263 (2022).","journal-title":"Front. Immunol."},{"key":"70075_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","volume":"98","author":"D Wojtal","year":"2016","unstructured":"Wojtal, D. et al. Spell checking nature: Versatility of CRISPR\/Cas9 for developing treatments for inherited disorders. Am. J. Hum. Genet. 98, 90\u2013101. https:\/\/doi.org\/10.1016\/j.ajhg.2015.11.012 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"70075_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","volume":"7","author":"A Lattanzi","year":"2017","unstructured":"Lattanzi, A. et al. Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR\/Cas9 system. Mol. Ther. Nucleic Acids 7, 11\u201319. https:\/\/doi.org\/10.1016\/j.omtn.2017.02.004 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"70075_CR18","doi-asserted-by":"publisher","first-page":"eaa9004","DOI":"10.1126\/sciadv.aap9004","volume":"4","author":"C Long","year":"2018","unstructured":"Long, C. et al. Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci. Adv. 4, eaa9004. https:\/\/doi.org\/10.1126\/sciadv.aap9004 (2018).","journal-title":"Sci. Adv."},{"key":"70075_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41434-022-00336-3","volume":"29","author":"DN Wang","year":"2022","unstructured":"Wang, D. N., Wang, Z. Q., Jin, M., Lin, M. T. & Wang, N. CRISPR\/Cas9-based genome editing for the modification of multiple duplications that cause Duchenne muscular dystrophy. Gene Ther. 29, 730\u2013737. https:\/\/doi.org\/10.1038\/s41434-022-00336-3 (2022).","journal-title":"Gene Ther."},{"key":"70075_CR20","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1038\/s41598-022-07671-w","volume":"12","author":"V Pini","year":"2022","unstructured":"Pini, V. et al. Transiently expressed CRISPR\/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications. Sci. Rep. 12, 3756. https:\/\/doi.org\/10.1038\/s41598-022-07671-w (2022).","journal-title":"Sci. Rep."},{"key":"70075_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013228","volume":"13","author":"E Maino","year":"2021","unstructured":"Maino, E. et al. Targeted genome editing in vivo corrects a Dmd duplication restoring wild-type dystrophin expression. EMBO Mol. Med. 13, e13228. https:\/\/doi.org\/10.15252\/emmm.202013228 (2021).","journal-title":"EMBO Mol. Med."},{"key":"70075_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/1471-2164-9-572","volume":"9","author":"M Bovolenta","year":"2008","unstructured":"Bovolenta, M. et al. A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies. BMC Genom. 9, 572. https:\/\/doi.org\/10.1186\/1471-2164-9-572 (2008).","journal-title":"BMC Genom."},{"key":"70075_CR23","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: Intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245. https:\/\/doi.org\/10.1093\/nar\/gky354 (2018).","journal-title":"Nucleic Acids Res."},{"key":"70075_CR24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308. https:\/\/doi.org\/10.1038\/nprot.2013.143 (2013).","journal-title":"Nat. Protoc."},{"key":"70075_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110972","author":"NR Dhoke","year":"2024","unstructured":"Dhoke, N. R. et al. A novel CRISPR-Cas9 strategy to target DYSTROPHIN mutations downstream of exon 44 in patient-specific DMD iPSCs. Cells. https:\/\/doi.org\/10.3390\/cells13110972 (2024).","journal-title":"Cells."},{"key":"70075_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pmr.2011.11.014","volume":"23","author":"JN Kornegay","year":"2012","unstructured":"Kornegay, J. N. et al. The paradox of muscle hypertrophy in muscular dystrophy. Phys. Med. Rehabil. Clin. N. Am. 23, 149\u2013172, xii. https:\/\/doi.org\/10.1016\/j.pmr.2011.11.014 (2012).","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"70075_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2044-5040-4-10","volume":"4","author":"RM Faber","year":"2014","unstructured":"Faber, R. M., Hall, J. K., Chamberlain, J. S. & Banks, G. B. Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice. Skelet. Muscle 4, 10. https:\/\/doi.org\/10.1186\/2044-5040-4-10 (2014).","journal-title":"Skelet. Muscle"},{"key":"70075_CR28","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.1038\/s41598-020-74192-9","volume":"10","author":"RT Massopust","year":"2020","unstructured":"Massopust, R. T. et al. Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss. Sci. Rep. 10, 17248. https:\/\/doi.org\/10.1038\/s41598-020-74192-9 (2020).","journal-title":"Sci. Rep."},{"key":"70075_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032229","author":"MV Dubinin","year":"2023","unstructured":"Dubinin, M. V. & Belosludtsev, K. N. Ion channels of the sarcolemma and intracellular organelles in duchenne muscular dystrophy: A role in the dysregulation of ion homeostasis and a possible target for therapy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24032229 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"70075_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14712598.2020.1725469","volume":"20","author":"DR Asher","year":"2020","unstructured":"Asher, D. R. et al. Clinical development on the frontier: Gene therapy for duchenne muscular dystrophy. Expert Opin. Biol. Ther. 20, 263\u2013274. https:\/\/doi.org\/10.1080\/14712598.2020.1725469 (2020).","journal-title":"Expert Opin. Biol. Ther."},{"key":"70075_CR31","doi-asserted-by":"crossref","unstructured":"Gupta, S., Sharma, S. N., Kundu, J., Pattanayak, S. & Sinha, S. Morpholino oligonucleotide-mediated exon skipping for DMD treatment: Past insights, present challenges and future perspectives. J. Biosci. 48 (2023).","DOI":"10.1007\/s12038-023-00365-z"},{"key":"70075_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li, T. et al. CRISPR\/Cas9 therapeutics: Progress and prospects. Signal Transduct. Target Ther. 8, 36. https:\/\/doi.org\/10.1038\/s41392-023-01309-7 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"70075_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young, C. S. et al. A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18, 533\u2013540. https:\/\/doi.org\/10.1016\/j.stem.2016.01.021 (2016).","journal-title":"Cell Stem Cell"},{"key":"70075_CR34","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1038\/ncomms7244","volume":"6","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G. et al. Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat. Commun. 6, 6244. https:\/\/doi.org\/10.1038\/ncomms7244 (2015).","journal-title":"Nat. Commun."},{"key":"70075_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky505","volume":"46","author":"M Dabrowska","year":"2018","unstructured":"Dabrowska, M. et al. qEva-CRISPR: A method for quantitative evaluation of CRISPR\/Cas-mediated genome editing in target and off-target sites. Nucleic Acids Res. 46, e101. https:\/\/doi.org\/10.1093\/nar\/gky505 (2018).","journal-title":"Nucleic Acids Res."},{"key":"70075_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa2107454 (2021).","journal-title":"N. Engl. J. Med."},{"key":"70075_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10565-019-09497-1","volume":"36","author":"M Haeussler","year":"2020","unstructured":"Haeussler, M. CRISPR off-targets: A question of context. Cell Biol. Toxicol. 36, 5\u20139. https:\/\/doi.org\/10.1007\/s10565-019-09497-1 (2020).","journal-title":"Cell Biol. Toxicol."},{"key":"70075_CR38","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.omtn.2022.11.017","volume":"30","author":"F Bizot","year":"2022","unstructured":"Bizot, F. et al. Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice. Mol. Ther. Nucleic Acids 30, 606\u2013620. https:\/\/doi.org\/10.1016\/j.omtn.2022.11.017 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"70075_CR39","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1073\/pnas.1910456117","volume":"117","author":"R Garcia-Rodriguez","year":"2020","unstructured":"Garcia-Rodriguez, R. et al. Premature termination codons in the DMD gene cause reduced local mRNA synthesis. Proc. Natl. Acad. Sci. USA 117, 16456\u201316464. https:\/\/doi.org\/10.1073\/pnas.1910456117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70075_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370\u2013375. https:\/\/doi.org\/10.1038\/nature22403 (2017).","journal-title":"Nature"},{"key":"70075_CR41","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nbt.1554","volume":"27","author":"K Miura","year":"2009","unstructured":"Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743\u2013745. https:\/\/doi.org\/10.1038\/nbt.1554 (2009).","journal-title":"Nat. Biotechnol."},{"key":"70075_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196238","volume":"13","author":"MIE Uusi-Makela","year":"2018","unstructured":"Uusi-Makela, M. I. E. et al. Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio). PLoS One 13, e0196238. https:\/\/doi.org\/10.1371\/journal.pone.0196238 (2018).","journal-title":"PLoS One"},{"key":"70075_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/nar\/gkad1076","volume":"52","author":"Y Ito","year":"2024","unstructured":"Ito, Y. et al. Epigenetic profiles guide improved CRISPR\/Cas9-mediated gene knockout in human T cells. Nucleic Acids Res. 52, 141\u2013153. https:\/\/doi.org\/10.1093\/nar\/gkad1076 (2024).","journal-title":"Nucleic Acids Res."},{"key":"70075_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108093","volume":"32","author":"JJ Shin","year":"2020","unstructured":"Shin, J. J. et al. Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells. Cell Rep. 32, 108093. https:\/\/doi.org\/10.1016\/j.celrep.2020.108093 (2020).","journal-title":"Cell Rep."},{"key":"70075_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui, K. et al. Immortalized pathological human myoblasts: Towards a universal tool for the study of neuromuscular disorders. Skelet. Muscle 1, 34. https:\/\/doi.org\/10.1186\/2044-5040-1-34 (2011).","journal-title":"Skelet. Muscle"},{"key":"70075_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13395-016-0115-5","volume":"6","author":"M Thorley","year":"2016","unstructured":"Thorley, M. et al. Skeletal muscle characteristics are preserved in hTERT\/cdk4 human myogenic cell lines. Skelet. Muscle 6, 43. https:\/\/doi.org\/10.1186\/s13395-016-0115-5 (2016).","journal-title":"Skelet. Muscle"},{"key":"70075_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"70075_CR48","doi-asserted-by":"publisher","unstructured":"Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17(1), 148. https:\/\/doi.org\/10.1186\/s13059-016-1012-2 (2016).","DOI":"10.1186\/s13059-016-1012-2"},{"key":"70075_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168. https:\/\/doi.org\/10.1093\/nar\/gku936 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70075-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70075-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70075-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T14:04:46Z","timestamp":1726063486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70075-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70075"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70075-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21238"}}